» Articles » PMID: 22946048

Autocrine Regulation of TGF-β1-induced Cell Migration by Exocytosis of ATP and Activation of P2 Receptors in Human Lung Cancer Cells

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2012 Sep 5
PMID 22946048
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

TGF-β1 plays a key role in cancer progression through induction of various biological effects, including cell migration. Extracellular nucleotides, such as ATP, released from cells play a role in signaling through activation of P2 receptors. We show here that exocytosis of ATP followed by activation of P2 receptors play a key role in TGF-β1-induced actin remodeling associated with cell migration. Treatment with TGF-β1 facilitated migration of human lung cancer A549 cells, which was blocked by pretreatment with ecto-nucleotidase and P2 receptor antagonists. ATP and P2 agonists facilitated cell migration. TGF-β1-induced actin remodeling, which contributes to cell migration, was also suppressed by pretreatment with ecto-nucleotidase and P2 receptor antagonists. Knockdown of P2X7 receptor suppressed TGF-β1-induced migration and actin remodeling. These results indicate the involvement of TGF-β1-induced ATP release in cell migration, at least in part, through activation of P2X7 receptors. TGF-β1 caused release of ATP from A549 cells within 10 minutes. Both ATP-enriched vesicles and expression of a vesicular nucleotide transporter (VNUT) SLC17A9, which is responsible for exocytosis of ATP, were found in cytosol of A549 cells. TGF-β1 failed to induce release of ATP from SLC17A9-knockdown cells. TGF-β1-induced cell migration and actin remodeling were also decreased in SLC17A9-knockdown cells. These results suggest the importance of exocytosis of ATP in cell migration. We conclude that autocrine signaling through exocytosis of ATP and activation of P2 receptors is required for the amplification of TGF-β1-induced migration of lung cancer cells.

Citing Articles

Integrated transcriptomic analysis reveals dysregulated immune infiltration and pro-inflammatory cytokines in the secretory endometrium of recurrent implantation failure patients.

Zhou P, Mo D, Huang H, Xu J, Liao B, Wang Y Life Med. 2025; 3(5):lnae036.

PMID: 39872439 PMC: 11749484. DOI: 10.1093/lifemedi/lnae036.


PDE5 inhibitor potentially improves polyuria and bladder storage and voiding dysfunctions in type 2 diabetic rats.

Kabuto T, Inamura S, Kobayashi H, Zha X, Nagase K, Taga M PLoS One. 2024; 19(9):e0301883.

PMID: 39292699 PMC: 11410213. DOI: 10.1371/journal.pone.0301883.


Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucoma.

Kannan V, Srimadh Bhagavatham S, Dandamudi R, Kunchala H, Challa S, Almansour A Front Mol Biosci. 2024; 11:1421030.

PMID: 39184151 PMC: 11341363. DOI: 10.3389/fmolb.2024.1421030.


Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells.

Nunez-Rios J, Reyna-Jeldes M, Mata-Martinez E, Campos-Contreras A, Lazcano-Sanchez I, Gonzalez-Gallardo A PLoS One. 2024; 19(6):e0304062.

PMID: 38870128 PMC: 11175443. DOI: 10.1371/journal.pone.0304062.


SLC17A9 as a prognostic biomarker correlated with immune infiltrates in human non-small cell lung cancer.

Gao Y, Chen Y, Liu M, Zeng D, Tan F, Wan H Am J Cancer Res. 2023; 13(9):3963-3982.

PMID: 37818081 PMC: 10560951.